AorTech International plc, a Scottish manufacture of cardiovascular devices, will specify 'PEEK-Optima' from Invibio Inc., for the frame of its next-generation synthetic tri-leaflet heart valve. The values are currently undergoing clinical tricals in the U.S. and Europe and are expected to be on the market as early as 2005.
展开▼
机译：苏格兰心血管设备制造商AorTech International plc将为其下一代合成三叶式心脏瓣膜的框架指定Invibio Inc.的“ PEEK-Optima”。这些值目前正在美国和欧洲进行临床测试，预计最早将于2005年投放市场。
展开▼
